| Quarterly Financials | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 100 | 184 | 138 | 148 | 146 | 162 | 235 | 241 | 226 | 239 | 198 | 173 | 219 | 253 | 217 | 247 | 214 | 223 | 153 | 139 | 137 | 154 | 168 | 138 | 176 | 201 | 222 | 179 | 196 | 175 | 211 | 188 | 165 | 225 | 206 | 204 | 188 | 223 | 226 | 210 | 243 | 253 | 237 | 268 |
| Expenses | 60 | 132 | 104 | 95 | 101 | 126 | 187 | 182 | 161 | 179 | 148 | 164 | 165 | 187 | 177 | 212 | 163 | 185 | 115 | 117 | 110 | 120 | 126 | 115 | 134 | 167 | 256 | 147 | 150 | 148 | 158 | 179 | 135 | 158 | 157 | 199 | 149 | 176 | 181 | 177 | 166 | 201 | 186 | 213 |
| EBITDA | 40 | 51 | 34 | 52 | 46 | 36 | 48 | 60 | 65 | 61 | 50 | 9 | 55 | 66 | 40 | 35 | 51 | 38 | 39 | 21 | 27 | 35 | 42 | 23 | 42 | 35 | -33 | 32 | 46 | 27 | 53 | 9 | 29 | 67 | 49 | 5 | 39 | 47 | 45 | 33 | 77 | 52 | 51 | 56 |
| Operating Profit % | 36 % | 25 % | 21 % | 34 % | 27 % | 21 % | 18 % | 27 % | 28 % | 20 % | 25 % | 2 % | 20 % | 18 % | 20 % | 13 % | 23 % | 12 % | 22 % | 2 % | 15 % | 21 % | 23 % | 13 % | 21 % | 15 % | -18 % | 12 % | 21 % | 14 % | 23 % | 3 % | 15 % | 26 % | 22 % | -0 % | 19 % | 19 % | 14 % | 11 % | 20 % | 18 % | 15 % | 17 % |
| Depreciation | 3 | 6 | 3 | 2 | 4 | 4 | 11 | 1 | 5 | 5 | 7 | 5 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 |
| Interest | 5 | 5 | 2 | 7 | 4 | 4 | 4 | 8 | 7 | 6 | 5 | 5 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 2 | 0 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 5 | 2 | 2 | 2 | 2 | 2 | 4 | 1 | 2 | 6 | 3 | 2 | 2 |
| Profit Before Tax | 33 | 41 | 31 | 43 | 41 | 36 | 38 | 60 | 56 | 52 | 39 | -1 | 51 | 63 | 37 | 32 | 47 | 34 | 34 | 13 | 20 | 30 | 37 | 17 | 37 | 30 | -39 | 27 | 39 | 20 | 47 | -1 | 22 | 59 | 40 | -4 | 30 | 36 | 36 | 23 | 63 | 41 | 41 | 45 |
| Tax | 13 | 13 | 7 | 15 | 13 | 15 | 17 | 18 | 19 | 12 | 13 | 12 | 12 | 21 | 9 | 13 | 14 | 3 | 9 | 8 | 4 | 8 | 10 | 8 | 11 | 8 | 10 | 3 | 12 | 4 | 18 | -4 | 7 | 16 | 11 | 1 | 8 | 10 | 11 | 7 | 19 | 12 | 16 | 8 |
| Net Profit | 20 | 28 | 24 | 29 | 28 | 21 | 22 | 43 | 37 | 40 | 26 | -14 | 39 | 42 | 27 | 19 | 33 | 31 | 26 | 6 | 17 | 22 | 28 | 8 | 26 | 22 | -49 | 24 | 28 | 16 | 30 | 4 | 14 | 43 | 29 | -5 | 22 | 26 | 26 | 17 | 44 | 29 | 25 | 37 |
| EPS in ₹ | 1.89 | 2.23 | 2.15 | 1.71 | 2.67 | 2.46 | 2.02 | 3.21 | 2.05 | 4.93 | 1.74 | -1.39 | 3.72 | 4.02 | 2.50 | 1.76 | 3.28 | 3.00 | 2.30 | 0.85 | 1.57 | 1.99 | 2.48 | 0.61 | 2.35 | 2.05 | -4.83 | 1.90 | 2.48 | 1.33 | 2.68 | 0.34 | 1.41 | 4.06 | 2.64 | -0.88 | 1.97 | 2.31 | 2.27 | 1.47 | 4.08 | 2.58 | 2.20 | 3.22 |
Bliss GVS Pharma
Bliss GVS Pharma
438.35
-17.85
(-3.91%)
Market Cap
4,637.26 Cr
PE Ratio
35.86
Volume
12,39,641.00
Day High - Low
455.95 - 433.10
52W High-Low
462.80 - 118.00
Key Fundamentals
Market Cap
4,637.26 Cr
EPS
12.23
PE Ratio
35.86
PB Ratio
4.05
Book Value
112.76
EBITDA
161.55
Dividend Yield
0.22 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
8.27
Debt to Equity
0.09
Actual
Company News
View All News
Bliss GVS Pharma Palghar Plant Wins WHO GMP Approval3 days ago
Bliss GVS Pharma's Palghar manufacturing plant has received WHO GMP compliance approval, marking a significant regulatory milestone for the company.
Anupam Rasayan India Limited has launched an open offer to acquire 26% of Bliss GVS Pharma Limited at ₹299 per share. The offer, totaling ₹829 crore, follows an agreement to purchase a 43.3% stake from existing promoters.
Independent Director Santosh Parab completed his second term at Bliss GVS Pharma on May 25, 2026. He ceased to be a director and committee member effective the close of business hours.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.20 | #1 4,27,609.48 | 37.09 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 43.33 | |
6,623.00 | 1,75,819.84 | 68.17 | 10,560.00 | 8.73 | 2,520 | 13.44 | 49.66 | |
4,420.90 | 1,49,623.34 | 68.66 | 13,886.20 | 20.34 | 2,138 | -26.91 | 53.32 | |
1,401.30 | 1,13,194.31 | 29.24 | 27,711.70 | -2.46 | 3,783 | -55.32 | 58.57 | |
1,089.00 | 1,09,578.88 | 21.32 | 26,719.70 | 13.65 | 5,242 | 7.82 | 71.01 | |
1,278.20 | 1,06,684.07 | 25.44 | 33,593.30 | -0.44 | 3,998 | -86.05 | 45.82 | |
2,267.70 | 1,03,643.69 | #1 19.20 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 47.04 | |
2,336.10 | 96,435.39 | 50.16 | 14,277.60 | 12.03 | 1,750 | 31.75 | 47.08 | |
1,462.30 | 84,930.62 | 24.27 | 33,384.70 | 3.21 | 3,376 | 1.99 | 53.78 | |
1,446.80 | 78,106.45 | 86.55 | 6,812.90 | #1 21.03 | 884 | 21.18 | 80.98 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
9.56 %
Net Income Growth
33.33 %
Cash Flow Change
3.01 %
ROE
1.72 %
ROCE
0.94 %
EBITDA Margin (Avg.)
-16.29 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 662 | 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| Fixed Assets | 234 | 225 | 305 | 143 | 146 | 242 | 234 | 282 | 379 | 370 | 406 | 458 |
| Current Assets | 417 | 471 | 566 | 690 | 694 | 770 | 765 | 777 | 697 | 811 | 827 | 946 |
| Capital Work in Progress | 0 | 9 | 4 | 1 | 47 | 0 | 2 | 22 | 3 | 8 | 21 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 4 | 4 | 151 |
| Other Assets | 428 | 527 | 714 | 717 | 712 | 786 | 840 | 803 | 768 | 830 | 870 | 0 |
| Total Equity & Liabilities | 662 | 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| Current Liabilities | 243 | 267 | 437 | 299 | 207 | 231 | 204 | 233 | 193 | 157 | 172 | 236 |
| Non Current Liabilities | 68 | 50 | 33 | 13 | 38 | 46 | 45 | 29 | 46 | 51 | 37 | 25 |
| Total Equity | 352 | 446 | 553 | 548 | 660 | 750 | 828 | 847 | 917 | 1,003 | 1,092 | 1,193 |
| Reserve & Surplus | 327 | 402 | 476 | 526 | 636 | 725 | 798 | 808 | 874 | 957 | 1,040 | 1,182 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -34 | 23 | 30 | -11 | -22 | 0 | -2 | 9 | 3 | -1 | 0 |
| Investing Activities | -30 | -50 | -249 | 48 | -79 | -40 | -45 | -103 | -6 | -83 | -75 |
| Operating Activities | 38 | 113 | 290 | 18 | 40 | 47 | 64 | 136 | 34 | 103 | 106 |
| Financing Activities | -42 | -40 | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 33.31 % | 33.24 % | 33.19 % | 33.14 % | 33.14 % | 34.51 % | 34.55 % | 34.46 % | 35.04 % | 35.12 % | 35.06 % | 34.97 % | 34.97 % | 34.90 % | 34.82 % | 35.10 % | 35.29 % | 35.44 % | 35.39 % | 35.36 % | 35.36 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 16.31 % | 0.00 % | 14.73 % | 13.25 % | 12.13 % | 13.51 % | 13.18 % | 12.65 % | 13.27 % | 14.54 % | 10.45 % |
| DIIs | 6.72 % | 6.72 % | 6.67 % | 6.66 % | 6.66 % | 6.65 % | 6.64 % | 6.63 % | 6.63 % | 6.62 % | 6.61 % | 6.59 % | 6.59 % | 6.58 % | 6.57 % | 6.55 % | 6.55 % | 6.54 % | 5.98 % | 5.78 % | 5.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.45 % | 26.90 % | 27.59 % | 28.26 % | 30.37 % | 30.15 % | 30.57 % | 30.74 % | 30.00 % | 30.10 % | 29.17 % | 30.78 % | 31.71 % | 32.84 % | 34.57 % | 32.93 % | 32.63 % | 32.79 % | 32.85 % | 31.48 % | 32.60 % |
| Others | 36.52 % | 33.14 % | 32.55 % | 31.95 % | 29.84 % | 28.69 % | 28.24 % | 28.18 % | 28.33 % | 28.15 % | 12.84 % | 27.66 % | 12.00 % | 12.43 % | 11.92 % | 11.91 % | 12.34 % | 12.58 % | 12.51 % | 12.84 % | 16.55 % |
| No of Share Holders | 28,543 | 39,999 | 42,742 | 41,080 | 45,866 | 46,327 | 45,753 | 44,983 | 43,041 | 42,182 | 43,234 | 40,758 | 45,157 | 44,737 | 52,937 | 49,558 | 49,517 | 46,707 | 44,461 | 43,380 | 44,874 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.6 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.00 |
| Dividend Yield (%) | 0.31 | 0.56 | 0.99 | 0.51 | 0.65 | 0.71 | 0.44 | 0.42 | 0.23 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 15 Jul 2026 |  Annual General Meeting | NA | 15 Jul 2026 | 271.25 | 438.05 |
| 14 Sept 2021 |  Dividend | ₹ 0.50 /share | 13 Sept 2021 | 122.40 | 110.50 |
| 21 Jun 2022 | Dividend | ₹ 0.50 /share | 20 Jun 2022 | 80.40 | 72.15 |
| 28 Jun 2022 | Annual General Meeting | NA | 28 Jun 2022 | 80.40 | 75.10 |
| 13 Jul 2023 | Dividend | ₹ 0.50 /share | 12 Jul 2023 | 82.15 | 82.95 |
| 19 Jul 2023 | Annual General Meeting | NA | 19 Jul 2023 | 83.76 | 101.70 |
| 19 Jul 2024 | Dividend | ₹ 0.50 /share | 18 Jul 2024 | 123.60 | 111.29 |
| 25 Jul 2024 | Annual General Meeting | NA | 25 Jul 2024 | 123.60 | 121.20 |
| 24 Oct 2024 |  Quarterly Result Announcement | NA | 24 Oct 2024 | 127.93 | 126.75 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 173.80 | 150.79 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 117.80 | 111.84 |
| 24 Jul 2025 | Dividend | ₹ 0.50 /share | 24 Jul 2025 | 111.84 | 156.90 |
| 29 Jul 2025 | Quarterly Result Announcement | NA | 29 Jul 2025 | 161.90 | 155.11 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 111.84 | 183.17 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 152.04 | 153.85 |
| 10 Feb 2026 | Quarterly Result Announcement | NA | 10 Feb 2026 | 172.77 | 203.75 |
| 18 Feb 2026 | Dividend | ₹ 0.50 /share | 18 Feb 2026 | 203.75 | 231.45 |
| 12 May 2026 | Quarterly Result Announcement | NA | 12 May 2026 | 274.10 | 271.25 |
Announcements
Intimation Of WHO-GMP Compliance Of Manufacturing Facility
3 days ago
3 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
3 days agoDetailed Public Statement4 days ago
4 days agoDetailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The Company4 days ago
4 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Public AnnouncementMay 25, 2026
May 25, 2026Disclosure under Regulation 30A of LODRMay 23, 2026
May 23, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 23 2026May 23, 2026
May 23, 2026Public Announcement In Relation To Open Offer To Public Shareholders (As Defined Under Public Announcement) Of The Company Under SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011May 23, 2026
May 23, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2026
May 12, 2026Corporate Action-Board approves DividendMay 12, 2026
May 12, 2026Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
May 12, 2026
May 12, 2026Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31 2026May 12, 2026
May 12, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday May 12 2026May 12, 2026
May 12, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 12, 2026
May 12, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 12, 2026
May 12, 2026Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend If Any For The Year Ended March 31 2026.May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Apr 10, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 09, 2026
Apr 09, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 06, 2026
Apr 06, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateApr 03, 2026
Apr 03, 2026Outcome Of The Circular Resolution Passed By The Board Of DirectorsApr 03, 2026
Apr 03, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2026
Apr 02, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10 2026Feb 17, 2026
Feb 17, 2026Rumour verification - Regulation 30(11)Feb 13, 2026
Feb 13, 2026Clarification On News Item Appearing In CNBC ????? On February 13 2026Feb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 10, 2026
Feb 10, 2026Corporate Action-Board approves DividendFeb 10, 2026
Feb 10, 2026Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019Feb 10, 2026
Feb 10, 2026Details Of Kmps For Reporting Of Disclosure Of Material Events To Stock ExchangesFeb 10, 2026
Feb 10, 2026Outcome Of Board Meeting Held On Tuesday February 10 2026Feb 10, 2026
Feb 10, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday February 10 2026Feb 10, 2026
Feb 10, 2026Board Meeting Intimation for The Meeting Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday February 10 2026.Feb 03, 2026
Feb 03, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 30, 2026
Jan 30, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 30, 2026
Jan 30, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Jan 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 31, 2025
Dec 31, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 30, 2025
Dec 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 23, 2025
Dec 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday December 23 2025Dec 23, 2025
Dec 23, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.13% | 0 | 0.00% | 0.02% | |
 Union Active Momentum Fund Direct-Growth | 0.77% | 0 | 0.00% | 0.77% |
Technical Indicators
RSI(14)
Neutral 75.91
ATR(14)
Volatile 22.83
STOCH(9,6)
Overbought 90.17
STOCH RSI(14)
Neutral 70.14
MACD(12,26)
Bullish 11.97
ADX(14)
Very Strong Trend 54.68
UO(9)
Bearish 64.05
ROC(12)
Uptrend And Accelerating 55.00
WillR(14)
Overbought -12.90
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
